Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1400 participants.
Also called NCT02446730
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,400 participants
- Registry
-
NCT02446730
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02446730. Randomized; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
- Acronym
- BEAUTY-II
- Condition
- Cardiac Death
- Condition
- Hemorrhage
- Condition
- Cerebrovascular Accident
- Condition
- Myocardial Infarction
- Intervention (Device)
- BES (biodegradable polymer biolimus-eluting stent)
- Intervention (Drug)
- Prasugel
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Chonnam National University Hospital
Record details
- Record id
cardio:ct-nct02446730- Content hash
b57b50231cf587028f9aaecc49851ecf7c74ad67928e7ca1d9342ec70e956e42